Masoprocol (meso-nordihydroguariaretic acid) is a potent 5-lipoxygenase inhibitor with antitumour properties, investigated for use in AK.100
Quality of evidence: I
We found two double-blind RCTs.62 100 The first study101 compared masoprocol (n = 113) with topical placebo (n = 41), and the second study62 compared masoprocol (n = 27) with topical 5% 5-FU (n = 30). Both studies reported 1-month follow up following end of treatment.
Was this article helpful?
Do You Suffer From the Itching and Scaling of Psoriasis? Or the Chronic Agony of Psoriatic Arthritis? If so you are not ALONE! A whopping three percent of the world’s populations suffer from either condition! An incredible 56 million working hours are lost every year by psoriasis sufferers according to the National Psoriasis Foundation.